The SGMO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGMO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SGMO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SGMO Detailed Price Forecast - CNN Money||View SGMO Detailed Summary - Google Finance|
|View SGMO Detailed Summary - Yahoo! Finance||View SGMO Stock Research & Analysis - Zacks.com|
|View SGMO Trends & Analysis - Trade-Ideas||View SGMO Major Holders - Barrons|
|View SGMO Call Transcripts - NASDAQ||View SGMO Breaking News & Analysis - Seeking Alpha|
|View SGMO Annual Report - CompanySpotlight.com||View SGMO OTC Short Report - OTCShortReport.com|
|View SGMO Fundamentals - TradeKing||View SGMO SEC Filings - Bar Chart|
|View Historical Prices for SGMO - The WSJ||View Performance/Total Return for SGMO - Morningstar|
|View the Analyst Estimates for SGMO - MarketWatch||View the Earnings History for SGMO - CNBC|
|View the SGMO Earnings - StockMarketWatch||View SGMO Buy or Sell Recommendations - MacroAxis|
|View the SGMO Bullish Patterns - American Bulls||View SGMO Short Pain Metrics - ShortPainBot.com|
|View SGMO Stock Mentions - StockTwits||View SGMO Stock Mentions - PennyStockTweets|
|View SGMO Stock Mentions - Twitter||View SGMO Investment Forum News - Investor Hub|
|View SGMO Stock Mentions - Yahoo! Message Board||View SGMO Stock Mentions - Seeking Alpha|
|View Insider Transactions for SGMO - SECform4.com||View Insider Transactions for SGMO - Insider Cow|
|View SGMO Major Holdings Summary - CNBC||View Insider Disclosure for SGMO - OTC Markets|
|View Insider Transactions for SGMO - Yahoo! Finance||View Institutional Holdings for SGMO - NASDAQ|
|View SGMO Stock Insight & Charts - FinViz.com||View SGMO Investment Charts - StockCharts.com|
|View SGMO Stock Overview & Charts - BarChart||View SGMO User Generated Charts - Trading View|
Why Wall Street Analysts Are Mostly Positive on CRISPR
Posted on Friday May 18, 2018
In December 2017, CRISPR Therapeutics (CRSP) entered a collaboration with Vertex Pharmaceuticals (VRTX) for the co-development and co-commercialization of CTX001. CRISPR Therapeutics submitted a CTA (clinical trial application) for CTX001 for the initiation of phase 1/2 trial for the evaluation of the safety and efficacy in the treatment of beta-thalassemia in Europe. CRISPR Therapeutics plans to submit an Investigational New Drug application to the FDA for the approval of an initiation of phase 1/2 clinical trial in the US for the treatment of sickle cell disease in the second half of 2018.
Sangamo Therapeutics Stock History
Posted on Thursday May 17, 2018
After decades of research into gene editing, this biotech company could be on the cusp of developing game-changing new treatments for rare diseases.
Bioverativ and Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease
Posted on Wednesday May 16, 2018
Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, and Sangamo Therapeutics, Inc. (SGMO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for BIVV003, a gene-edited cell therapy candidate for the treatment of people with sickle cell disease. Bioverativ and Sangamo are developing BIVV003 as part of an exclusive worldwide collaboration to develop and commercialize gene-edited cell therapies for sickle cell disease and beta thalassemia.
Edited Transcript of SGMO earnings conference call or presentation 8-May-18 12:00pm GMT
Posted on Sunday May 13, 2018
Q1 2018 Sangamo Therapeutics Inc Earnings Call